sports | Business | Health | food | Technology | money |
Ontario will be pausing the rollout and administration of first doses of the AstraZeneca-Oxford COVID-19 vaccine, effective Tuesday, due to concerns over rare but potentially fatal blood clots.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.